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ABSTRACT
Objective To determine whether integration of nutritional
supplementation with other public health programmes in
early life reduces the risk of cardiovascular disease in
undernourished populations.
Design Approximately 15 years’ follow-up of participants
born within an earlier controlled, community trial of
nutritional supplementation integrated with other public
health programmes.
Setting 29 villages (15 intervention, 14 control) near
Hyderabad city, south India.
Participants 1165 adolescents aged 13-18 years.
Intervention Balanced protein-calorie supplementation
(2.51 MJ, 20 g protein) offered daily to pregnant women
and preschool children aged under 6 years, coupled with
integrated delivery of vertical public health programmes.
Main outcome measures Height, adiposity, blood
pressures, lipids, insulin resistance (homoeostasismodel
assessment (HOMA) score), and arterial stiffness
(augmentation index).
Results The participants from the intervention villages
were 14 mm (95% confidence interval 4 to 23; P=0.007)
taller than controls but had similar body composition. The
participants from the intervention villages had more
favourable measures of insulin resistance and arterial
stiffness: 20% (3% to 39%; P=0.02) lower HOMA score
and 3.3% (1% to 5.7%; P=0.008) lower augmentation
index. No strong evidence existed for differences in blood
pressures and serum lipids.
Conclusions In this undernourished population,
integrated delivery of supplemental nutrition with other
public health programmes in pregnancy and early
childhood was associated with a more favourable profile
of cardiovascular disease risk factors in adolescence. This
pragmatic study provides the most robust evidence to
date on this important hypothesis for which classic trials
are unlikely. Improved maternal and child nutrition may
have a role in reducing the burden of cardiovascular
disease in low income and middle income countries.
INTRODUCTION
Some authors have suggested that the risk of cardio-
vascular diseases can be “programmed” in early life
through the persistence of endocrine, physiological,
and metabolic adaptations made in the face of
undernutrition.1 2 The proposition that inadequate
diet in early life may result in heightened sensitivity
to lifestyle related risk factors is of some importance to
the unfolding cardiovascular disease epidemic in low
income and middle income countries, where under-
nutrition and urbanisation now often coexist.3
The evidence in support of this hypothesis is largely
circumstantial: animal experiments and observational
studies in humans showing associations between
anthropometric measures (as proxies for undernutri-
tion) and risk of cardiovascular disease.1 2 4 5 Direct
evidence of a relation between inadequate diet in early
life and later risk of cardiovascular disease is almost
non-existent. The importance of balanced protein-
calorie reduction has been studied in two natural
experiments of starvation and one small randomised
controlled trial of nutrition supplementation, but the
results have been inconclusive.6-9 We therefore exam-
ined the prevalence of risk factors for cardiovascular
disease in adolescents born within an earlier commu-
nity trial of nutritional supplementation offered to
pregnant women and young children.10
METHODS
Integrated Child Development Services is a national
community based programme aimed at improving the
health, nutrition, and development of children in
India.11 12 The centrepiece of this programme is the
provision of free food: a cereal based meal prepared
variably from locally available ingredients but
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providing on average about 2.09 MJ and 20-25 g
protein to pregnant/lactating women and about 1.25
MJ and 8-10 g protein to children up to 6 years. The
supplement has to be collected daily by the woman (or
her children) from the Integrated Child Development
Services centre (run by a local woman trained for this
programme), but they are not obliged to eat it there. To
ensure that the impact of food supplementation on the
child’s nutritional status is not undermined by ill
health, diarrhoea, and frequent infections, the pro-
gramme is complemented by health, hygiene, and
nutrition education for the mothers and delivery of
other national programmes (immunisation, anaemia
control, and basic health care) from the Integrated
Child Development Services centre. These other
programmes are available universally (that is, in the
control area too), but we anticipate that a common
point of delivery increases their uptake in the
Integrated Child Development Services programme
by making it more convenient.11-13
Initial trial design (1987-90)
Using the opportunity afforded by the stepwise
expansion of this programme during the 1980s and
1990s, the National Institute of Nutrition in India ran a
trial to assess (among other things) the impact of food
supplementation in pregnancy on the birth weight of
offspring.A cluster of villageswith a total populationof
30 000 was chosen from each of the two adjacent
administrative areas (called “blocks”), one of which
already had the Integrated Child Development Ser-
vices programme in place (intervention arm), whereas
the other was awaiting implementation (control arm).
As the 100 or more villages in each of the two blocks
were spreadover anunfeasibly large area, villageswere
chosen geographically for random selection: contig-
uous villages falling within a 10 km radius of a
prominent central village (deemed to be the approx-
imate centre of the block on visual inspection of the
area map) in each block were selected. This process
resulted in 15villages from the intervention armand14
villages from the control arm being recruited to the
study.
A 12 member team of investigators resided full time
in the field for the duration of the study. Following a
lead-in period of six months (involving training, pilot
data collection, and household enumeration to identify
women in the reproductive age group—13-45 years),
the trial included all births in the area between 1
January 1987 and 31 December 1990. The “at risk” (of
pregnancy) women were monitored monthly to detect
missing of menstruation, and those identified as
pregnant were followed closely during pregnancy
until delivery (with clinical examinations in each of
the three trimesters). The field team attempted to visit
the home as soon as possible after delivery to collect
data on the outcome of the pregnancy and to weigh the
newbornwithin 48 hours. An infant beambalancewith
a 20 g accuracy (JohnChatillon & Sons, NY, USA) was
used to measure weight.
The supplement given in this trial was “upma,” a
local preparation made from corn-soya blend (120 g)
and soybean oil (16 g), providing 2.51 MJ and 20 g
protein to the women and half this amount to the
children. No other nutrients (such as micronutrients,
iodised salt) were added to the supplement. The other
universal programmes—immunisation, anaemia con-
trol in pregnancy through distribution of iron (60 mg
elemental) and folic acid (500 μg) tablets, and the
provision of basic health care—existed to a similar
extent in both the intervention and control areas,
although their uptake may be presumed to have been
higher in the intervention area. Crossover of supple-
ments from intervention to control villages was not a
problem because of their separation by a large number
of villages not involved in the study; in addition,
supplements were offered only to the named residents
of the village. A preliminary abstract reported the
ongoing study,10 but full findings were unreported.
Follow-up survey (2003-5)
Wedesigned this follow-up study to establish the status
of women and their offspring who took part in the trial
and to clinically examine offspring who were still
resident in the area. The parents and children gave
written informed consent.
We did two parallel surveys on a village to village
basis—the first to identify the studyparticipants and the
second to do clinical examinations. The identification
survey preceded the clinical survey by three months,
and we interchanged the survey area between inter-
vention and control villages every couple of months to
even out any variations arising from seasons and
experience of the study team. In the identification
survey, we first identified women who took part in the
baseline trial by using their own and their husband’s
name. We interviewed each woman thus identified to
collect details on children she had previously borne.
All childrenborn in these villages during the initial trial
period (1987-90) were potential study participants.
However, owing to limited resources and to make
maximal use of the baseline data, we invited only those
children who could be successfully matched to the
previous records to have clinical examinations. We
used date of birth and sex for matching, as infants’
names were not recorded in the baseline study
(traditionally, naming is delayed and not done at the
time of birth in India). Where multiple children of the
same woman were eligible, we invited them all and
made appropriate adjustments in the analyses.
Weuseda single clinic site at eachvillage (generally a
central point such as the village hall or health centre) to
reduce measurement error arising from differences in
clinic conditions. We held clinics in the morning, and
invited 10-15 children to come fasting each day. We
completed a full interviewer administered question-
naire and clinical examination on the children and a
brief questionnaire on the mothers (who were asked to
accompany the child).
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Measurements
We measured height with a portable stadiometer
(Leicester height measure; Chasmors, London). The
participant stood erect with his or her head in the
Frankfort plane, and a gentle upward pressure was
applied under the mastoid.We used a digital weighing
machine (HD 305; Tanita, Tokyo, Japan) to measure
weight. We measured skinfold thickness at four sites
(biceps, triceps, subscapular, and suprailiac) in tripli-
cate with the Holtain calliper (supplied by Chasmors,
London). We used a validated oscillometric device
(HEM 705; Omron, Matsusaka Co, Japan) to measure
blood pressure in the supine position with appropriate
cuff sizes; we took two measurements and averaged
them for analyses. We measured ambient room
temperature with a digital thermometer.
We assessed the augmentation index, a measure of
global arterial stiffness, by using an applanation
tonometry technique with the Sphygmocor apparatus
(Vx system; Atcor (PWV) Medical, Sydney,
Australia).14 The characteristic pressure waveform
produced by blood flow in the arteries changes as the
arteries get stifferwith ageor under conditions that lead
to their premature stiffening (such as atherosclerosis).15
Pulse wave analysis can therefore be used to assess the
functioning of the vascular tree. Pressure waveforms
are obtained non-invasively by applying a pressure
sensitive probe over a peripheral artery and trans-
formed into the corresponding central arterial wave-
form by using a generalised transfer function validated
against invasive pressure recordings.14 The augmenta-
tion index (difference between the first and second
peaks of the central arterial waveform, expressed as a
percentage of pulse pressure) is negative in healthy
young adults but becomes increasingly positive as
arteries stiffen.15Wemeasured the augmentation index
over the radial artery in the supine position, taking an
average of two high quality recordings (quality index
>90%).
We classified sexual maturation into four stages
(corresponding to Tanner’s early, middle, and late
puberty andpost-puberty) on the basis of time since the
onset of menstruation (girls) and testicular volume
(boys).16 The boys self assessed testicular volume in
private, using Prader’s orchidometer (a chain of 12
wooden testes with volumes ranging from 1 ml to
25 ml).Wemeasured socioeconomic position with the
standard of living index, which is a household level,
asset based scale devised for use in India.17 We
classified theparticipants as having low (0-14),medium
(15-24), or high (25-67) socioeconomic position. We
assessed urbanisation of the villages by population size
(people) and classified them into low (<2000), medium
(2000-5000), and high (>5000).
We collected fasting blood samples (at least eight
hours) in appropriate vacutainers, transferred them
within one to two hours (in icebox at 4-8° C), and
processed them within four hours. We did assays for
glucose, triglycerides, total cholesterol, and high
density lipoprotein cholesterol on the same day with
an autoanalyser (ACE Clinical System; Schiapparelli
Biosystems, NJ, USA) and the recommended kits (Alfa
Wasserman, NJ, USA). We estimated insulin concen-
trationsby radioimmunoassay inbatcheswithin four to
six weeks.18
Quality control
We produced detailed protocols and used them
regularly to standardise the work of the fieldwork
team. “Blinding” of the fieldworkers to the group
assignment was not an option; however, all measure-
ments except anthropometry were to a large extent
automated (for example, biochemical assays, blood
pressure, and arterial stiffness), thus reducing the
possibility of bias. Only one observer made each
measurement (including biochemical assays), to elim-
inate interobserverbias.Weassessed reproducibility of
clinic measurements by repeating the measurements
ona randomsubsample (5%)ofparticipants afterone to
three weeks and found it to be consistently high
(intraclass correlation coefficients of >0.98 for anthro-
pometric measures and >0.85 for blood pressures and
augmentation index). We put in place internal and
external quality control arrangements (with Cardiac
Biochemistry laboratory at the All India Institute of
Medical Sciences, Delhi, which is part of UKNEQAS
systemcoordinated fromNewcastle,UK) for biochem-
ical assays, and split assays were done on a 5%
subsample (intraclass correlation coefficients >0.94).
We validated testicular self assessment technique
against a trained observer in a separate substudy and
Not contacted (n=467, 33%):
  Unknown (n=299, 21%)*
  Temporary residents at baseline
    (n=41, 3%)†
  Out-migrants (n=123, 9%)
  Currently away (n=4, <1%)
Not contacted (n=326, 25%):
  Unknown (n=168, 13%)
  Temporary residents at baseline
    (n=40, 3%)†
  Out-migrants (n=111, 8%)
  Currently away (n=7, <1%)
Community trial (1987-90)
Restricted to those with historical records
Control villages (n=14)Intervention villages (n=15)
Families with identifiers (n=1429)Families with identifiers (n=1327)
Attended clinic (n=511, 74% )§Attended clinic (n=654, 82%)§
Invited to clinic (n=691)Invited to clinic (n=801)
Families contacted  (n=962, 67%)Families contacted (n=1001, 75%)
Children born to date (4125)
  Died (n=529, 13%)‡
Children born to date (4121)
  Died (n=423, 10%)‡
Live children, born 1987-90 (n=1259)Live children, born 1987-90 (n=1342)
Flow chart of participant recruitment at follow-up in Hyderabad nutrition trial. *Higher figure in
control area probably reflects greater influx of temporary migrant workers during harvest season.
†Married daughters of villagerswhowere temporarily visiting their parents’ home for childbirth at
timeof baseline study. ‡Data are for all children (rather thanstudy cohort), as date of birth of dead
children was not collected (deemed insensitive). §These represent 49% (intervention) and 41%
(control) of all eligible births
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found it to be highly accurate (mean difference in
model ranks (self reported minus directly observed)—
0.07 (95% confidence interval −0.11 to 0.25)—with no
evidence of systematic bias on a Bland-Altman plot).
Statistical analyses
Weused the log of the sumof four skinfolds to calculate
the percentage of body fat19 20; we then converted this
into fat and fat-free mass by using body weight and
expressed them as the corresponding indices after
dividing them by the square of height in metres.21 We
assessed central adiposity by the ratio of central
(subscapular plus suprailiac) to peripheral (biceps
plus triceps) skinfolds. We estimated low density
lipoprotein cholesterol from triglycerides, total choles-
terol, and high density lipoprotein cholesterol by using
the Friedewald-Fredrickson equation,22 and we calcu-
lated insulin resistance by homoeostasis model assess-
ment (HOMA), excluding those with fasting glucose
≥7 mmol/l.23
We applied suitable transformations to outcome
variables that deviated markedly from a normal
distribution (triglycerides, insulin, andHOMAscores).
We used linear regression models to investigate
association of supplemental nutrition with cardio-
vascular disease risk factors. Analysis was on an
intention to treat basis, using area of birth as proxy
(irrespective of whether the participant took the
supplement or not). We fitted four predefined models
to adjust incrementally for the main domains of
potential confounding or intermediary variables:
model 1 (physiological variables—age, sex, pubertal
stage); model 2 (current socioeconomic status—house-
hold standard of living index, village population);
model 3 (stature—height); and model 4 (body compo-
sition—fatmass index, fat-freemass index, and central-
peripheral skinfold ratio). We additionally adjusted
blood pressure for ambient room temperature and
augmentation index for heart rate, as these factors can
artefactually affect their values.24 25 We assessed
association of supplemental nutrition with sexual
maturation (by ordinal and binary logistic regression),
as improved nutrition may influence risk of cardio-
vascular disease through earlier onset of puberty.26
Data could be clustered at the level of the village and
the household (in case of multiple children). To take
account of village level clustering, we used robust
standard errors in all the models, with village as the
level of cluster. This technique uses the cluster level
residuals to derive the standard errors, so that the
resulting standard errors are larger and valid in the
presence of clustering but the parameter estimate
remains unchanged. This technique was inappropriate
for household level clustering, as very few households
had multiple children taking part in the study. We
therefore examined the impact of household level
clustering on the results by excluding the second of the
two children from the same household (no household
contained more than two children). We similarly
estimated the impact of a few migrant children (who
usually lived outside the area but happened to be at
home during the study) on the results by excluding
these children from the final models. We examined
interaction between the intervention and the sex of the
participant, as evidence exists of preferential feeding of
male children in this setting,27 as well as possible sex
differential effects of early undernutrition on risk of
cardiovascular disease.28 To retain maximum study
power, we examined only one interaction. We used
Stata version 9 for statistical analyses.
Sample size calculations done before the start of the
study suggested that the anticipated sample (estimated
as 1268 overall) was going to be adequate to detect
important differences in most outcomes (for example,
at 80%power, 5% significance level, and 0.01 intraclass
correlation coefficient for village level clustering, the
mean detectable differences were 1.8-2.9 mm Hg for
systolic blood pressure, 1.5% for augmentation index,
and 1.7-3.2 mU/l for insulin).
RESULTS
Of the 4338 pregnancies recorded in the trial, birth
weights (recorded within 48 hours) were available for
2964 (68%)children.Themeanbirthweightof children
born in the intervention area (2655 (SD 424) g) was
higher than that of controls (2594 (SD430) g); themean
differencewas 61 g (95% confidence interval 18 to 104;
P=0.007). Adjustment for sex of the child made no
difference to the results; however, we deemed data on
Table 1 | Characteristics of childrenwho attended and thosewhodid not attend clinical examination at follow-up in Hyderabad
nutrition trial. Values are numbers (percentages) unless stated otherwise
Characteristic
Intervention area (n=1342) Control area (n=1259)
Clinic
attenders
(n=654)
Clinic non-
attenders
(n=688) P value*
Clinic
attenders
(n=511)
Clinic non-
attenders
(n=748) P value*
Mean (SD) age (years) 15.5 (0.9) 15.1 (1.2) <0.001 15.7 (0.9) 15.3 (1.2) <0.001
Male 349 (53) 338 (49) 0.12 279 (55) 355 (47) 0.013
Occupation: (n=653) (n=686) 0.001 (n=745) 0.012
Full time student 529 (81) 496 (72) 372 (73) 507 (68)
Full time employment 84 (13) 126 (18) 96 (19) 194 (26)
Others (neither, both) 40 (6) 64 (9) 43 (8) 44 (6)
*Based on unpaired t tests or χ2 tests for heterogeneity with appropriate degrees of freedom.
P values for interaction tests between intervention area and clinic attendance: age (P=0.4), male sex (P=0.5), and occupation (P=0.07).
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gestational age to be of insufficient quality (strong digit
preference) to be included in the analyses. Personal
information (necessary to trace families) was available
for 2756 women, of which 1963 (71%) could be
contacted successfully (figure). At the time of follow-
up, the contacted women had delivered 8246 children,
of which 2601 were eligible for follow-up (born
between 1987 and 1990 and still alive in 2003). From
these eligible children, we invited only those with
existing information in the trial dataset (n=1492; 57%)
to have a clinical examination. A total of 1165 children
participated in the clinics: 654 (82%) in the intervention
area and 511 (74%) in the control area, representing
45% of all eligible births from the area at the time.
Childrenwho tookpart in the clinicswere slightlyolder
and more likely to be males and students than those
who were eligible but did not participate (table 1).
Three girls who reported being pregnant were
excluded from the analyses. Of the remaining 1162
children, we excluded those with missing data on key
confounders and, for biochemical parameters only,
those who had fasted for less than eight hours. Finally,
complete data were available for 1120 (96%) children
for at least one outcome, with slightly fewer for blood
pressure (1118; 96%), lipid profile (1050; 90%),
glucose-insulin (1008; 87%), and arterial stiffness
(862; 74%). The lower number with glucose-insulin
data was due to a failure to obtain insulin assay reagent
in time for the last batch of assays (n=48), and that for
arterial stiffness datawasdue to an inability to complete
all assessmentsduring the courseof a clinic day, asmost
villages lacked the continuous electricity supply
needed to run the apparatus. Some, but not all, of the
participants returned subsequently to have their
assessments completed.
Table 2 shows the distributions of key exposures,
which were largely similar across the two areas. The
distribution of the standard of living index was
consistent with the peri-urban situation of these
villages. Only two children reported smoking tobacco
or consuming alcohol, and all except two were breast
fed, so we did not consider these variables in further
analyses. Table 3 shows the data for themain outcome
measures by the area of intervention. The distributions
of triglycerides, insulin concentration, and HOMA
score were positively skewed but log-normal. We
therefore present geometric means and logged regres-
sion coefficients for these. Body composition data
confirm the short, lean habitus of this population. The
mean values for indices of insulin resistance (insulin
and HOMA score) and, to a smaller extent, arterial
stiffness (although data are limited) were higher than
those generally reported from high income countries,
suggesting a pro-atherogenic profile in this under-
nourished population.29 30 The average number of
participants from each village was 40 (range 2-122).
Village level clustering of outcome measures was less
than 0.1, except for fasting blood glucose (0.14). All
results are based on models with robust standard
errors, with village as the level of cluster.
Children in the intervention and control arms were
not different in their sexual maturation (data not
shown). Table 4 shows the results of multivariably
adjusted associations between supplemental nutrition
and risk factors for cardiovascular disease. Children in
the intervention area were on average 14 (95%
confidence interval 4 to 23) mm taller than the control
children but similar in body composition. Systolic
blood pressure (but not diastolic blood pressure) was
slightly higher in the control area, although the
difference did not reach conventional levels of
statistical significance. The augmentation index
showed an association with supplemental nutrition,
which was unlikely to be due to chance and was hardly
altered by multivariable adjustments; higher values
(stiffer arteries) were seen in the control area. Lipids
and glucose were not associated with supplemental
nutrition. However, children in the control arm had
higher insulin concentration andHOMA score, robust
to adjustments for height and body composition
(identical results for insulin and HOMA due to high
correlation). The regression coefficients shown in
Table 2 | Distribution of key exposures in participantswho
completed clinic questionnaires at follow-up inHyderabad
nutrition trial.Valuesarenumbers (percentages)unlessstated
otherwise
Characteristic
Intervention
area (n=633)
Control area
(n=498) P value*
Mean (SD) age (years) 15.8 (0.9) 15.9 (0.9) 0.02
Male 333 (53) 274 (55) 0.4
Pubertal stage†: (n=628) (n=496) 0.4
Early puberty 88 (14) 83 (17)
Middle puberty 209 (33) 156 (31)
Late puberty 184 (29) 132 (27)
Post-puberty 147 (23) 125 (25)
Standard of living
index:
(n=630) 0.2
High (25-67) 228 (36) 158 (32)
Medium (15-24) 291 (46) 239 (48)
Low (0-14) 111 (18) 101 (20)
Own occupation‡: (n=497) 0.002
Student/vocational
training
534 (84) 391 (79)
Employed 66 (10) 53 (11)
Unemployed/
housework
33 (5) 53 (11)
Literate mother§ 58 (9) 57 (11) 0.2
Lifestyle: (n=497)
Consumed tobacco
(ever)
0 2 (0) 0.2
Consumed alcohol
(ever)
0 2 (0) 0.2
*P values are based on unpaired t tests or χ2 tests for heterogeneity with
appropriate degrees of freedom.
†Pubertal stage for boys: intervention area—early 27%, middle 56%,
late 18%, post-puberty 0%; control area—early 30%, middle 50%, late
19%, post-puberty 0%. Pubertal stage for girls: intervention area—early
0%, middle 8%, late 42%, post-puberty 50%; control area—early 0%,
middle 9%, late 35%, post-puberty 56%.
‡Vocational training, n=15; unemployed, n=36.
§Literate/primary school, n=45; middle school, n=43; high school, n=16;
intermediate level, n=9; graduate, n=2.
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table 4 for insulin and HOMA score are differences
between the means on the log scale; the HOMA score
value for model 2 equates to 20% (95% confidence
interval 3% to 39%) higher values in the control
children (on the original scale). We found little
evidence to support a sex differential effect of nutri-
tional supplementation (data not shown). Limiting the
analyses to childrenwith information on augmentation
index or HOMA score did not change the results for
other outcomes materially.
The study included 36 sibling pairs, of which five
pairswere twins; all other households contributed only
one child to the study. Thirty two participants had
migrated away from their place of birth, of which nine
had migrated within the study area (all except one had
migrated within their own category of area—that is,
intervention or control). Exclusion of the migrant
children or the second child (in the case of sibling pairs)
made no material difference to the results.
DISCUSSION
This is the first intervention study to show that modest
improvements in theprotein-calorie intake of pregnant
women and young children may result in a more
favourable cardiovascular disease risk factor profile
among populations with prevalent undernutrition.
These findings may indicate potential life course
pathways underlying the causes of cardiovascular
diseases in general.31 These observations, if replicated,
have important implications for the primary
prevention of cardiovascular diseases in low income
andmiddle incomecountries, as the intervention tested
was pragmatic, cheap, and relatively easy to imple-
ment.
Comparison with previous research
The importance of balanced protein-calorie malnutri-
tion in early life has been studied in two natural
experiments based on the starvation experience of
populations under siege in the second world war
(Dutch and Leningrad studies) and one small rando-
mised controlled trial of supplemental nutrition from
Guatemala.6-9 Whereas the Dutch study reported
associations with adiposity and dyslipidaemia (early
gestation starvation) and with abnormal glucose
homoeostasis (late gestation starvation), these findings
were not replicated in the Leningrad study.7 8 The
Guatemala trial randomised four villages within pairs
tooffer either lowenergy (1.38MJ)orhighenergy (3.76
MJ, proteins, and micronutrients) supplements to
pregnant women and children until the age of
7 years.6 9 Follow-up at age 24 years suggested no
association of supplement typewith adiposity or blood
pressure but an association of higher energy supple-
ment with lower fasting glucose in women only. One
potential reason for the negative findings could be that
these studies were underpowered, with sample sizes of
741 (68 in early gestation, 120 in late gestation
starvation categories) in the Dutch study, 549 (169
with intrauterine starvation) in the Leningrad study,
Table 3 | Distribution of outcome variables by area of intervention at follow-up inHyderabad nutrition trial
No
Mean (SD) Mean difference* (95% CI)
(control minus intervention)Intervention Control
Body size and composition
Height (mm) 1120 1559 (83) 1549 (82) −10.0 (−18.7 to −1.4); P=0.024
Body mass index (kg/m2) 1120 17.1 (2.0) 17.3 (2.4) 0.27 (−0.08 to 0.61); P=0.1
Fat mass index (kg/m2) 1120 2.6 (1.3) 2.6 (1.5) −0.02 (−0.23 to 0.19); P=0.8
Fat-free mass index (kg/m2) 1120 14.5 (1.4) 14.8 (1.6) 0.29 (0.01 to 0.57); P=0.043
Central-peripheral skinfold
ratio
1120 1.48 (0.25) 1.47 (0.25) −0.01 (−0.06 to 0.05); P=0.8
Cardiovascular physiology
Systolic blood pressure (mm
Hg)
1118 108.7 (10.3) 109.6 (10.0) 0.83 (−1.44 to 3.11); P=0.5
Diastolic blood pressure
(mm Hg)
1118 62.5 (6.5) 62.2 (6.5) −0.23 (−1.70 to 1.25); P=0.8
Augmentation index (%) 862 2.5 (11.4) 5.6 (9.1) 3.16 (0.8 to 5.51); P=0.011
Lipid profile
Total cholesterol (mmol/l) 1050 3.45 (0.69) 3.45 (0.67) −0.00 (−0.12 to 0.12); P=1.0
LDL cholesterol (mmol/l) 1050 2.05 (0.60) 2.04 (0.59) −0.02 (−0.13 to 0.09); P=0.8
HDL cholesterol (mmol/l) 1050 0.99 (0.23) 1.00 (0.22) 0.01 (−0.05 to 0.06); P=0.7
Triglycerides† (mmol/l) 1050 0.82 (0.39 to 1.72) 0.83 (0.40 to 1.74) 0.02 (−0.04 to 0.07); P=0.6
Glucose homeostasis
Glucose (mmol/l) 1008 4.68 (0.58) 4.72 (0.74) 0.03 (−0.23 to 0.29); P=0.8
Insulin† (mU/l) 1008 15.36 (5.07 to 46.52) 18.45 (6.37 to 53.41) 0.18 (0.03 to 0.33); P=0.02
HOMA score† 1003 3.16 (1.00 to 10.00) 3.79 (1.22 to 11.73) 0.18 (0.04 to 0.32); P=0.015
HDL=high density lipoprotein; HOMA=homoeostasis modal assessment; LDL=low density lipoprotein.
*Based on linear regression models with robust standard errors.
†Values for intervention and control areas are geometric means and 95% reference ranges; mean differences are on log scale.
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and 450 (167 women) in the Guatemala study.
Alternatively, the exposuremay have been inadequate
for programming of long term physiological changes,
in terms of either strength (mean birth weights in all
three studies were greater than 3.0 kg) or duration (the
two natural experiments).
Strengths and limitations
The main strength of this study is its setting: a
nutritional intervention in a population with high
background levels of chronic undernutrition, so we
could realistically expect to find programming effects
of inadequate diet, if they exist. The controlled design
of the original evaluation would have reduced the
chances of confounding; furthermore, the crucial
confounders were either completely absent (maternal
smoking) or severely restricted (socioeconomichetero-
geneity and urbanisation, with the consequent hetero-
geneity in diet and physical activity behaviour).32 The
age group (adolescence) was also ideal for studying
exposures in early life, as the participants were old
enough to show variations in risk factors but young
enough that anyassociations seenwerenot distortedby
any differences in adult lifestyle in the intervening
years.
The study also has some important limitations that
need to be acknowledged, chief among them the
potential for bias owing to non-randomisation of
villages in the baseline study, losses to follow-up, and
lack of data on current diet and patterns of physical
activity. In the baseline study, all villages within a
radius of the central village were selected in both
intervention and control areas, making selection bias
unlikely. Bias could arise, however, if the intervention
area urbanised at a different rate from the control area,
thus influencing the prevalence of risk factors for
cardiovascular disease. Data on urbanisation (such as
population size and density; proportion of households
with television; and availability of facilities such as
electricity, bank, and health centre) collected from the
village heads showed little variation between the
villages (data not shown), and adjustment for urbanisa-
tion (population size) did notmaterially alter any of the
results. Areas considered deprived are prioritised for
the introduction of the Integrated Child Development
Services programme in phases; however, the staggered
introduction of the programme in similarly deprived
and adjacent areas (such as those in the study) ismainly
due to financial and operational constraints associated
with the introduction of a public programme in a large
country (about 75% of the villages have been covered
in the past 30 years or so, and the programme is still
being rolledout).11 12The introductionof the Integrated
Child Development Services programme in control
areas started in 1992-3, as a result of which some
children could have received the supplement when
Table 4 | Multivariable association* between supplemental nutrition and cardiovascular disease risk factors at follow-up in
Hyderabad nutrition trial
Measure
β coefficient (95% CI); P value
Model 1† Model 2‡ Model 3§ Model 4¶
Height (mm) −14.1 (−23.3 to −4.9);
0.004
−13.6 (−23.1 to −4.1);
0.007
NA NA
Fat mass index (kg/m2) 0.01 (−0.15 to 0.16); 0.9 0.04 (−0.10 to 0.18); 0.5 0.06 (−0.07 to 0.19); 0.4 NA
Fat-free mass index (kg/m2) 0.23 (0.03 to 0.43); 0.029 0.04 (−0.10 to 0.18); 0.5 0.28 (0.11 to 0.46); 0.003 NA
Central-peripheral skinfold
ratio
−0.02 (−0.06 to 0.03); 0.5 −0.02 (−0.08 to 0.03); 0.4 −0.01 (−0.07 to 0.05); 0.7 NA
Systolic blood pressure (mm
Hg)
0.86 (−0.72 to 2.45); 0.2 0.59 (−1.11 to 2.29); 0.4 1.10 (−0.68 to 2.87); 0.2 0.64 (−0.99 to 2.27); 0.4
Diastolic blood pressure
(mm Hg)
0.21 (−0.81 to 1.23); 0.7 0.08 (−0.90 to 1.07); 0.8 0.21 (−0.77 to 1.19); 0.6 0.11 (−0.85 to 1.07); 0.8
Augmentation index (%) 3.29 (0.74 to 5.84); 0.013 3.30 (0.96 to 5.65); 0.008 2.84 (0.39 to 5.30); 0.025 2.96 (0.55 to 5.38); 0.018
Total cholesterol (mmol/l) 0.01 (−0.11 to 0.12); 0.9 −0.02 (−0.11 to 0.08); 0.7 −0.02 (−0.12 to 0.07); 0.6 −0.03 (−0.13 to 0.06); 0.5
LDL cholesterol (mmol/l) −0.01 (−0.12 to 0.09); 0.8 −0.03 (−0.13 to 0.07); 0.6 −0.03 (−0.13 to 0.07); 0.5 −0.04 (−0.14 to 0.06); 0.4
HDL cholesterol (mmol/l) 0.01 (−0.05 to 0.06); 0.7 −0.00 (−0.06 to 0.05); 1.0 −0.00 (−0.06 to 0.05); 0.9 −0.00 (−0.06 to 0.05); 0.9
Triglycerides (mmol/l)** 0.02 (−0.03 to 0.07); 0.4 0.03 (−0.03 to 0.08); 0.3 0.02 (−0.03 to 0.08); 0.4 0.02 (−0.03 to 0.07); 0.4
Glucose (mmol/l) 0.04 (−0.22 to 0.29); 0.8 0.03 (−0.21 to 0.26); 0.8 0.03 (−0.21 to 0.26); 0.8 0.04 (−0.20 to 0.28); 0.8
Insulin (mU/l)** 0.18 (0.04 to 0.32); 0.016 0.18 (0.03 to 0.34); 0.02 0.19 (0.04 to 0.35); 0.016 0.19 (0.03 to 0.35); 0.016
HOMA score** 0.18 (0.04 to 0.32); 0.014 0.18 (0.03 to 0.33); 0.021 0.19 (0.04 to 0.35); 0.016 0.19 (0.03 to 0.34); 0.02
HDL=high density lipoprotein; HOMA=homoeostasis model assessment; LDL=low density lipoprotein; NA=not applicable.
Sample size: n=1120 for height, fat mass index, fat-free mass index, and central-peripheral skinfold ratio; n=1118 for systolic and diastolic blood
pressure; n=862 for augmentation index; n=1050 for total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides; n=1008 for glucose and
insulin; n=1003 for HOMA score.
*Linear regression models with robust standard errors.
†Adjusted for age, sex, pubertal stage (early puberty, middle puberty, late puberty, and post-puberty), room temperature (blood pressure only), and
heart rate (augmentation index only).
‡Adjusted for variables in model 1 plus current socioeconomic circumstances (household’s standard of living index (high, medium, low) and village
urbanisation (village population <2000, 2000-5000, >5000)).
§Adjusted for variables in model 2 plus height (mm).
¶Adjusted for variables in model 3 plus body composition (fat mass index, fat free mass index, and central-peripheral skinfold ratio).
**Differences (between means) are on log scale.
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they were 3-6 years old, potentially diluting the effect
estimate. However, such programmes take time to get
established, with substantial uptakes only after several
years, rendering this bias unimportant. The pro-
gramme has continued since its introduction in both
the intervention and control areas, but children over
the age of 6 cannot use its services as they are not
beneficiaries in the programme.11 12
The response rate among children invited to the
clinic was high (78%), although it was somewhat lower
in the control areas, which in all probability arose from
lack of interest in participation in the study shown by
heads of some of the control villages (as local elections
were taking place at the time). Loss to follow-up
resulting from this is likely to be non-systematic. The
participating children represented 45% of all eligible
births in the area from that time, which compares
favourably with the overall follow-up rates in other
relevant studies (all below 35%).6-9 Comparisons of
participating childrenwith the remaining childrenwho
were eligible but did not participate (using limited
available information) showed them to be little
different. The most important reason for failing to
trace all eligible participants, we believe, was the
inclusion of temporary migrant workers in the initial
study, as such participants would not have remained in
the village at the time of the follow-up study.
Unfortunately, this information was not recorded in
the initial trial. Lack of this and other baseline data as a
result of limited matching precluded any meaningful
use of sophisticated techniques for handling missing
data (such as imputation). Bias in the results due to
incomplete follow-upcannot be ruledout, so the results
should be interpreted with some caution.
Differences in current diet and patterns of physical
activity could account for the differences seen in risk of
cardiovascular disease. Although it is theoretically
possible, we see no obvious reason to believe that
children from these neighbouring villages hadmarked
differences in lifestyle. The villages are still fairly
homogeneous in their diet (limited rangeof foods eaten
mostly at home) andactivitypatterns (generally active).
Furthermore, no differences in body composition
existed; as adiposity reflects the net energy balance
between intake (diet) and expenditure (physical
activity), the low fat mass in this population and its
narrow distribution range, argues against any impor-
tant lifestyle differences between the two areas. Finally,
despite the relative automation of most of the outcome
measures used in this study (including insulin resis-
tance and arterial stiffness), the possibility of bias
arising from the lack of blinding of the fieldworkers
cannot be ruled out completely.
Potential mechanisms
Insulin resistance is believed to be central to many of
the changes attributed to the thrifty phenotype.4 33 If the
fetus develops insulin resistance in times of under-
nutrition, this may improve the short term chances of
survival but predispose to cardiovascular disease on
persistence into adult life.34-37 Arterial stiffness is a
relatively novel risk factor for atherosclerosis.38
Whether it is a risk marker for atherosclerosis or an
independent risk factor for cardiovascular disease is
unclear.38-40 However, various other programming
pathways are believed to culminate in a self perpetuat-
ing cycle of increasing blood pressure and arterial
stiffness, which promotes atherosclerosis.38 39 Insulin is
a risk factor for arterial stiffness and may be the link
between early undernutrition, arterial stiffness, and
hypertension.41 42
The relative importanceofnutrition in various stages
(pregnancy, infancy, early childhood), sources of
nutrition, or indeed the rate of growth in early versus
late postnatal life cannot be delineated from this study,
as the intervention was given throughout.43 The other
public health programmes (such as health education
and immunisation) were available in both intervention
and control areas, but they may have had greater
uptake in the intervention area owing to their integra-
tion with the nutritional component. Data on the
uptakeof these componentswerenot available, so their
independent effects on the results cannotbe ruledout.44
However, evidence suggests that their contribution to
cardiovasculardisease risk, if any, ismore likely tohave
been mediated through improvements in the nutri-
tional status, by helping to break the vicious cycle of
infections, diarrhoea, and malnutrition found in these
settings.45
Public health implications
We need to contextualise our observations and
consider what public health benefits may accrue if
this intervention was translated into primary preven-
tion of disease burden. The Anglo-Cardiff collabora-
tive study suggested that a 3% lower augmentation
index equates to a three year less aged vascular
phenotype.29 Given the age of the study population,
this would be a substantial gain; however, extreme
caution in interpretation is warranted because of
differences in study setting and design. Similarly,
extrapolating the data from a meta-analysis of studies
on insulin concentrations and risk of cardiovascular
disease also suggests a potential 8% reduction in
cardiovascular disease risk of the supplemented
children.36 Although these improvements are substan-
tial in themselves, evenmore important is the potential
for these risk factors to interact with the behavioural
risk factors in adulthood, resulting in a major amplifi-
cation in the risk difference.1 34
The intervention in this study was given within the
framework of a public welfare programme.11 12 In such
programmes, the supplement is collected by only
about half of the eligible women and often shared
among other family members; the study therefore
probably underestimates the potential benefit. On the
other hand, the effects of dietary supplements on the
nutritional statusof the childwereprobablyaugmented
by other components of the programme, such as health
education and immunisation. This study therefore
provides realistic estimates of the benefit that can be
expected from supplemental nutrition given in the
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context of “holistic” programmes to tackle under-
nutrition in children. Such programmes already exist
around much of the developing world,46 but their
advisability is being questioned in view of the
epidemics of obesity and cardiovascular disease.47
For example, a previous cohort study from India
found that risk of diabetes and impaired glucose
tolerance was associated with thinness at age 2 years
and increased adiposity at 12 years.48 Our results
provide some reassurance about the longer term
benefits of improving maternal and childhood nutri-
tion in undernourished populations. At this stage in the
participants’ life course, this intervention does not
seem to increase the risk of obesity and may even
decrease (not increase) the future risk of cardiovascular
disease.
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